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Abstract
Objective: Major birth defects are inborn structural or functional anomalies with long-term disability and adverse 
impacts on individuals, families, health-care systems, and societies. Approximately 20% of birth defects are due 
to chromosomal and genetic conditions. Inspired by the fact that neonatal deaths are caused by birth defects in 
about 20 and 10% of cases in Iran and worldwide respectively, we conducted the present study to unravel the role 
of chromosome abnormalities, including microdeletion/microduplication(s), in multiple congenital abnormalities 
in a number of Iranian patients.
Materials and Methods: In this descriptive cross-sectional study, 50 sporadic patients with Multiple Congenital 
Anomalies (MCA) were selected. The techniques employed included conventional karyotyping, fluorescence in 
situ hybridization (FISH), multiplex ligation-dependent probe amplification (MLPA), and array comparative genomic 
hybridisation (array-CGH), according to the clinical diagnosis for each patient.              
Results: Chromosomal abnormalities and microdeletion/microduplication(s) were observed in eight out of fifty patients 
(16%). The abnormalities proved to result from the imbalances in chromosomes 1, 3, 12, and 18 in four of the patients. 
However, the other four patients were diagnosed to suffer from the known microdeletions of 22q11.21, 16p13.3, 5q35.3, 
and 7q11.23.               
Conclusion: In the present study, we report a patient with 46,XY, der(18)[12]/46,XY, der(18), +mar[8] dn presented 
with MCA associated with hypogammaglobulinemia. Given the patient’s seemingly rare and highly complex 
chromosomal abnormality and the lack of any concise mechanism presented in the literature to justify the case, 
we hereby propose a novel mechanism for the formation of both derivative and ring chromosome 18. In addition, 
we introduce a new 12q abnormality and a novel association of an Xp22.33 duplication with 1q43q44 deletion 
syndrome. The phenotype analysis of the patients with chromosome abnormality would be beneficial for further 
phenotype-genotype correlation studies. 
Keywords: Array Comparative Genomic Hybridization, Chromosomal Abnormalities, Congenital Abnormalities, 
Microdeletions, Multiplex Ligation-Dependent Probe Amplification
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Introduction
Major birth defects are considered to be inborn 
structural or functional abnormalities which could 
be diagnosed prenatally, at birth, or later in infancy, 
or even in adulthood. Their consequence will be 
a long-term disability with major adverse effects 
on individuals, families, health-care systems, and 
societies (1). Approximately 20% and more than 10% 
of all neonatal deaths in Iran and worldwide (2) are 
caused by birth defects, respectively. The incidence of 
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major birth defects in neonatals, resulting from genetic 
or partially genetic factors, is about 7.9 million per 
year (3). A fifth (20.2%) of the cases with birth defects 
are attributed to a known etiology comprising of 
chromosomal (15.8%) and genetic (3.8%) conditions. 
Teratogens are the cause of 0.8% of cases,  0.3% of 
them are caused by twinning, and four-fifths (79.8%) 
are categorized to be of unknown etiology (1). Nearly, 
20 to 30% of the infants suffering from birth defects 
have multiple congenital anomalies (MCA) involving 
different organs. In cases where two or more major 
congenital abnormalities occur in several organs and 
the defects do not represent a sequence or a complex 
series, the case is classified as MCA (4). 
Genetic factors are regarded as one of the most 
prominent etiologies of MCA (1). Also, chromosomal 
abnormalities have been known to be one of the 
leading causes of intellectual disability (ID) as well 
as congenital malformations. A large number of 
chromosomal defects can be detected immediately 
through high-resolution karyotyping technique. But, 
the resolution of the cytogenetic analysis is restricted 
to around 5 to 10 Mb. Among molecular cytogenetic 
techniques, fluorescence in situ hybridization (FISH) 
and multiplex ligation-dependent probe amplification 
(MLPA) are two of the targeted tests used to detect 
submicroscopic chromosome abnormalities. Genome-
wide molecular cytogenetic tests like array comparative 
genomic hybridisation (array-CGH) can identify a 
variety of copy number variants (CNVs) associated 
with MCA. Array-CGH, as a powerful test, is applied 
to investigate individuals with MCA, ID, and autism 
spectrum disorders (5). In the current study, we 
aimed at identifying the chromosomal abnormalities 
and microdeletion/microduplication(s) in 50 Iranian 
patients with MCA. The patients manifested diverse 
phenotypes including ID/developmental delay (DD), 
and at least one major congenital anomaly in another 
organ. Existence of additional minor dysmorphic 
features was also considered among the factors 
representing chromosomal abnormalities which led to 
an increase in the detection rate.
Materials and Methods
Selection of patients
In this descriptive cross-sectional study conducted 
during the three past years from April 2015 to May 
2018, clinical evaluation was performed for 50 selected 
sporadic patients suffering from MCA preferably born 
to unrelated parents and referred to us by experienced 
clinical specialists for genetic investigation from all 
over the country. All of the patients had ID/DD with 
at least one major anomaly and additional minor 
dysmorphic features. All of the steps taken for testing 
and procedures were fully explained for all of the 
probands’ parents, and signed informed consent forms 
from all of the participants were obtained for publishing 
any information or accompanying photographs. This 
study was approved by the Ethics Committee of the 
University of Social Welfare and Rehabilitation 
Sciences (IR.USWR.REC.1394.186).
Conventional karyotyping 
A conventional cytogenetic study was carried out on 
peripheral blood lymphocytes using GTG high-resolution 
banding technique according to standard protocols for 
all patients (6). Twenty GTG banded metaphases were 
examined through the complete analysis of each individual 
sample. Chromosome analysis was performed according 
to ISCN 2016 (7). 
Fluorescence in situ hybridization
Metaphase FISH was done only for patient 9 using 
the centromeric probe of chromosome 18 (Kreatech/
Leica Biosystems Buffalo Grove, IL, USA, http://www.
leicabiosystems.com) according to Kreatech protocol 
(8). Two hundred cells were examined to characterize the 
ring chromosome origin defined in 37% of cells by high-
resolution GTG banding. 
Multiplex ligation-dependent probe amplification          
MLPA technique was done using P245 Microdeletion 
Syndromes-1 kit (MRC-Holland, Amsterdam, the 
Netherlands) for the patients suspected of microdeletion/
microduplication syndromes. MLPA protocol was 
performed based on the instructions provided by the 
manufacturer, MRC Holland, and the data were analyzed 
utilizing capillary electrophoresis in the 3130XL DNA 
Analyzer, Coffalyser. Net software (MRC-Holland, 
Amsterdam, the Netherlands) and Gene Marker software 
version 2.7.0 (Softgenetics, State College, PA, USA). 
Abnormal results obtained with MLPA assay were 
repeated and if different, further investigations were 
carried out with array-CGH. MLPA studies were done 
for the patients’ parents with abnormal results in order 
to determine the causal role (de novo or inherited) of 
microdeletions. 
Array comparative genomic hybridization
The analysis of oligonucleotide array-CGH 
for Genomic DNA was carried out. To do so, the 
BlueGnome CytoChip ISCA 8×60 K v2.0 whole-
genome oligo array was utilized for patients 1, 5, 
9, 13, and 41. This array included intragenic and 
intergenic probe spacings of about 48 kb and 70 kb, 
respectively and high probe density in 500 clinically 
important regions. CytoSNP-850K v1.1 BeadChip 
overall effective resolution of about 18 Kb was used 
for patient 27. The tests were performed based on 
the manufacturer’s protocol. INNOPSYS 910 laser 
scanner was utilized for scanning according to the 
recommended protocol of the manufacturer. Image 
analysis and base calling were carried out employing 
the BlueFuse Multi-version 3 analysis software for 
oligo array and Multi-version 4.4 analysis software 
Cell J, Vol 21, No 3, October-December (Autumn) 2019339
Mohammadzadeh et al.
for SNP array. The analysis of the samples was carried 
out two times against two non-identical controls 
and representation of minimum three clones on the 
platform in both of the experiments was considered 
to approve the imbalances. To evaluate the called 
CNVs, we utilized the standards and guidelines of 
American College of Medical Genetics and Genomics 
to interpret the postnatal constitutional CNVs (5). All 
chromosome coordinates are on the basis of GRCh37.
p13/hg19.
Results
Based on the selection criteria, the patients had MCA, 
i.e., having ID/DD and at least one major congenital 
anomaly in another organ plus additional minor facial 
dysmorphic features. The clinical characteristic features 
of all patients with MCA are summarized in Table 1. The 
participants included 25 male and 25 female patients. Their 
ages ranged from 7 months to 21 years with a median age 
of 3.25 years and an average of about 5.1 years (Table 1).
Excluding ID/DD, the most common clinical features 
from the highest frequent to the lowest frequent 
were congenital heart defects in 45 patients (90%), 
craniofacial dysmorphic features in 31 patients (62%), 
musculoskeletal, ear and genitourinary abnormalities, 
each one in 19 patients (38%), eye abnormalities in 
16 patients (32%), gastrointestinal abnormalities in 
5 patients (10%), and endocrine abnormalities in 3 
patients (6%) (Table 2). 
In patient 9, a 31-month-old boy from 
consanguineous parents (half first cousins) and born 
to a 27-year-old G1P1L1A0 (G: gravid, P: parity, L: 
live birth, A: abortus) mother, the clinical features 
were global DD, PDA, PFO, optic nerve hypoplasia, 
hypogammaglobulinemia, facial dysmorphic features, 
microcephaly, and mild ventriculomegaly in frontal 
horns in the axial spiral CT-scan of the brain without 
contrast, and benign extra-axial hydrocephalus and 
atrophic changes in the brain magnetic resonance 
imaging (MRI). The karyotype analysis by high-
resolution GTG banding showed 46,XY, der(18)
[12]/46,XY, der(18), +mar[8] dn (Fig.1A1, 2). Since 
in both cell lines of the patient the short arm of one 
chromosome 18 (18p) was abnormal and one cell line 
had an additional ring chromosome, one hundred cells 
were screened to obtain the percentage of the cells with 
marker ring chromosome. The karyotype analyses of 
the proband’s parents were normal. Metaphase FISH 
using the centromeric probe for chromosome 18 
indicated three hybridization signals for chromosome 
18 in 37% of the cells scored which was consistent with 
mosaic trisomy 18, nuc ish(D18Z1×3)[37]/(D18Z1×2) 
[63] dn (Fig.1A3, 4). Further investigations using 
array-CGH demonstrated the exact breakpoints of 
the derivative chromosome 18 and its deletion and 
duplication (Fig.1A5).
Fig1: Results of cytogenetic/molecular cytogenetic analysis of patients 9, 17, and 41. A1. Abnormal G-banded chromosomes 18 observed in all spreads, 
A2. 37% of spreads included ring 18, der(18)  and normal 18 from left to right, A3, A4. FISH results using centromeric probe for chromosome 18  (arrowed), 
A5. Array-CGH profile of chromosome 18 utilizing the BlueGnome CytoChip ISCA 8x60K v2.0 whole genome oligo array, B1. G-banded der(4), B2. 
Balanced translocation of chromosomes 4 and 12, and C. G-banded chromosomes 3 with 3p25.3p26.3 deletion. The normal idiograms of the mentioned 
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Table 1: The clinical features of 50 patients with MCA
Patient Sex Age Clinical findings
1 F 14 month DD, SVAS, SVPS, IUGR, Hypotonia, Left visual defect, Facial dysmorphic features, Strabismus, ADHD, Dental 
problems, Congenital hypothyroidism
2 M 25 month DD, VSD, ASD, Pulmonary hypertension, Microcephaly, Facial dysmorphic features, UDT, Small testes
3 F 8 Y ID, TOF, PDA, Microcephaly, DD, Aggressiveness, Umbilical hernia, Flat feet, Syndactyly 
4 M 3.5 Y DD, ASD, PDA, Bilateral congenital glaucoma, Hypotonia, Bilateral club feet, Bilateral hip dislocation (grade 
4), Bilateral hydronephrosis, Bilateral inguinal hernia and hydrocele, Hypothyroidism
5 F 5.5 Y ID, Large ASD, Epilepsy, Autistic behavior, Macrocephaly, Dolicocephaly, Facial dysmorphic features, Sparse 
hair, Joint laxity, Severe left renal reflux
6 F 6 Y ID, VSD, ASD, Microcephaly, Bilateral club feet, Joint stiffness
7 M 2.5 Y DD, Large ASD, Bilateral SNHL, Bilateral hydronephrosis, Dysphagia, Hypotonia, Polydactyly
8 M 3.5 Y DD, TR, Facial paralysis, Left SNHL
9 M 31 month Global DD, PDA, PFO, Hypotonia, Optic nerve hypoplasia, Facial dysmorphic features, Recurrent lower 
respiratory tract infection, Hypogammaglobulinemia, Dysphagia, Microcephaly, Speech disorder, Hypertelorism, 
Micrognathia, Clinodactyly, Rocker bottom feet, Short stature, Fecal/urinary incontinence
10 M 4 Y DD, Severe AS, Severe PS, ASD, Facial dysmorphic features, Brachydactyly, Clinodactyly, Flat feet, Hirsutism
11 F 4 Y DD, TOF, IUGR, Hypotonia, ADHD, Insomnia, Microcephaly, Facial dysmorphic features, Brachydactyly, 
Bilateral simian creases, Low-set ears
12 M 1.5 Y DD, TOF, Hypotonia, Facial dysmorphic features, Low-set ears, Bilateral UDT 
13 M 3 Y DD, VSD, AR, Bilateral SNHL, Facial dysmorphic features, Bilateral UDT, Speech delay, Malformed, 
Posteriorly rotated and low set ears, Simian crease, 5th toe clinodactyly, Umbilical hernia, Sacral mongolian spot, 
Right lower limb paresis, Joint contractures, Bilateral pachygyria
14 M 4.5 Y DD, TOF, Hypotonia, Bilateral SNHL, Urinary reflux
15 M 3 Y DD, Large ASD, Hypotonia, Microcephaly, Facial dysmorphic features, High-arched palate
16 F 3 Y DD, ASD, Hypotonia, Facial dysmorphic features, Speech delay, Macrocephaly, Wide anterior fontanel
17 M 8.5 
month
ID, DD, PDA, ASD, Hypotonia, Facial dysmorphic features, Infantile spasms and myoclonic jerks, Hearing loss, 
Bilateral simian creases, Corpus callosum hypoplasia, Growth retardation, Abnormal EEG, Microcephaly, Short 
neck, Malformed ears, Low-set ears, High-arched palate, Camptodactyly, Joint hyperlaxity, Imperforated anus, 
Umbilical hernia, Bilateral UDT, Small kidneys 
18 M 5.5 Y ID, Large ASD, PS, PDA, Hypotonia, Long philtrum, Visual defect, Bilateral inguinal hernia
19 F 3.5 Y DD, Severe PS, Facial dysmorphic features
20 F 3 Y DD, TOF, Bilateral congenital anophthalmia, Absence of manubrium
21 F 2 Y DD, ASD, Bilateral SNHL, Facial dysmorphic features, Right periauricular and periorbital tags, Rectovaginal 
fistula, Right lower lid coloboma
22 M 7 Y ID, VSD, Hypotonia, Corpus callosum hypoplasia, DD, Facial dysmorphic features
23 M 2.5 Y DD, TGA, Bilateral SNHL, Strabismus, High-arched palate, Clinodactyly
24 M 2 Y DD, Large VSD, PDA, Pulmonary hypertension, Left SNHL, Microcephaly, Bilateral UDT, Ambiguous genitalia
25 F 5.5 Y ID, Large VSD, Pulmonary hypertension, Hypotonia, Visual defect, Epilepsy, Bilateral simian creases, 
Microcephaly, Hyperreflexia
26 M 2 Y DD, TOF, Hypotonia, Facial dysmorphic features
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Table 1: Continued
Patient Sex Age Clinical findings
27 M 18 Y ID, TOF, DD, Microcephaly, Hypotonia, Severe scoliosis, Short stature, Facial dysmorphic features, Myopia, 
Strabismus, High-arched palate, Low-set ears, Left UDT, Growth retardation, Speech delay, Flat feet
28 M 2.5 Y DD, Large ASD, TA, Short and bifid sternum, Hypotonia
29 M 2 Y DD, Large VSD, PS, Dextrocardia
30 M 3 Y DD, PDA, PS, PFO, Hypotonia, Bilateral ptosis, Strabismus, Bilateral UDT
31 F 10 month DD, TA, PDA, VSD, ASD, Dolicocephaly
32 M 15.5 Y ID, VSD, Epilepsy, Autism, Facial dysmorphic features, Retrognathia, Low-set ears, Joints hypermobility, 
Bilateral club feet, Polydactyly (right foot)
33 F 1.5 Y DD, ASD, Bilateral SNHL, Cleft palate, Facial dysmorphic features, Hip dislocation, Simple cyst (Left kidney) 
34 F 8 Y ID, ASD, Autism, Hirschsprung, Bilateral inguinal hernia, Hypopigmentation of neck and back
35 F 7 month DD, ASD, Peripheral  PS, Ascending aorta dilatation, Bilateral cataracts, Facial dysmorphic features, Left ptosis, 
Low set ears, Micrognathia
36 M 2 Y DD, PFO, Moderate bilateral SNHL, Hypotonia, Convulsion, Abnormal EEG, Hydrocephalus, Bilateral optic 
nerve atrophy
37 F 1 Y DD, Large VSD, PFO, Pulmonary hypertension, Macroglossia, Facial dysmorphic features, Flat feet
38 F 12 Y ID, TR, MVP, Macrocephaly, Ventriculomegaly (in MRI), Short stature, FTT, Ureteral stenosis, Facial 
dysmorphic features, Left ptosis, Photophobia, Ichthyosis, Sparse hair
39 F 15 month DD, Dilated right atrium and ventricle, Dilated pulmonary artery, Hypotonia, Chest deformity, Vermis 
hypoplasia, Prominent diameters frontal horns of lateral ventricles in brain sonography
40 F 20 month DD, ASD, PFO, Choanal atresia, Bilateral lower lid coloboma, Low-set ears, Brain hemiatrophy, Macroglossia
41 F 10 Y ID, Autism, Facial dysmorphic features, Microcephaly, Bilateral SNHL, Epilepsy, Polydactyly (4 limbs), Low 
birth weight, Growth retardation, Abnormal EEG, Hypotonia, Trigonocephaly, Short stature, Triangular face, 
Ptosis, Low-set ears, Posteriorly rotated ears, Retrognathia, Micrognathia, Downturned mouth, High-arched 
palate, Fecal/urinary incontinence, Feeding problems
42 F 15 month DD, VSD, ASD, RVH, Choanal atresia, Strabismus, Nasolacrimal duct obstruction, Bulbous nose
43 F 21 Y ID, Autism, ADHD, Insomnia, Severe obesity, Aggressiveness
44 F 7 Y ID, Autism, Bilateral lower lid coloboma, Facial dysmorphic features, Microcephaly, Retrognathia
45 F 11 Y ID, Autism, Diabetes mellitus
46 F 10 Y ID, Autism, Facial dysmorphic features, Low-set ears, Urinary incontinence, Right small kidney
47 F 7.5 Y ID, VSD, Epilepsy, Postaxial polydactyly (4 limbs), Syndactyly 
48 M 8.5 Y ID, VSD, ASD, Facial dysmorphic features, Cleft lip and palate, Strabismus
49 M 6.5 Y ID, VSD, DD, Facial dysmorphic features, Left ureteral stenosis
50 M 9 Y ID, VSD, Epilepsy, Bilateral SNHL, Facial asymmetry, Strabismus, Microcephaly, Cleft lip/palate
MCA; Multiple congenital anomalies, F; Female, M; Male, AR; Aortic regurgitation, AS; Aortic stenosis, ASD; Atrial septal defect, DD; Developmental delay, 
FTT; Failure to thrive, ID; Intellectual disability, IUGR; Intrauterine growth restriction, MVP; Mitral valve prolapse, PDA; Patent ductus arteriosus, PFO; 
Patent foramen ovale, PS; Pulmonic stenosis, RVH; Right ventricular hypertrophy, SNHL; Sensorineural hearing loss, SVAS; Supravalvular aortic stenosis, 
SVPS; Supravalvular pulmonic stenosis, TA; Tricuspid atresia, TGA; Transposition of the great arteries, TOF; Tetralogy of fallot, UDT; Undescended testis/
testes, VSD; Ventricular septal defect, ADHD; Attention deficit/hyperactivity disorder, EEG; Electroencephalography, TR; Tricuspid regurgitation, and MRI; 
Magnetic resonance imaging.
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 Table 2: Frequency of main phenotypic manifestations of 50 patients
with MCA categorized by organ systems
Phenotype n (%)
Craniofacial 31 (62)*
      Facial dysmorphic features 27 (54)
      Microcephaly 13 (26)
      Macrocephaly 3 (6)
      Cleft lip/palate 3 (6)
      Dolicocephaly 2 (4)
Central nervous system 50 (100)
      ID/DD 50 (100)
      Hypotonia 20 (40)
      Epilepsy 8 (16)
      Corpus callosum agenesis 2 (4)
Cardiovascular system 45 (90)*
      ASD 19 (38)
      VSD 15 (30)
       PS 8 (16)
       PDA 8 (16)
       TOF 7 (14)
       Pulmonary hypertension 4 (8)
       PFO 4 (8)
       AS 2 (4)
Musculoskeletal system 19 (38)*
       Short stature 4 (8)
       Polydactyly 4 (8)
       Club foot 3 (6)
       Syndactyly 2 (4)
       Brachydactyly 2 (4)
       Clinodactyly 2 (4)
Ear 19 (38)*
       SNHL 11 (22)
       Low-set ear (s) 9 (18)
Eye 16 (32)*
       Strabismus 6 (12)
       Hypertelorism 5 (10)
       Ptosis 4 (8)
       Visual defect 3 (6)
 Table 2: Continued
Phenotype n (%)
       Lower lid coloboma 3 (6)
       Optic nerve hypoplasia 2 (4)
       Glaucoma 1 (2)
       Cataract 1 (2)
Genitourinary system 19 (38)
       UDT 7 (14)
       Urinary incontinence 3 (6)
       Small kidney 2 (4)
       Urinary reflux 2 (4)
       Small testes 1 (2)
       Hydrocele 1 (2)
       Ureteral stenosis 1 (2)
       Rectovaginal fistula 1 (2)
       Simple kidney cyst 1 (2)
Gastrointestinal system 5 (10)
       Dysphagia 2 (4)
       Fecal incontinence 2 (4)
       Hirschsprung 1 (2)
Endocrine system 3 (6)
      Hypothyroidism 2 (4)
      Diabetes mellitus 1 (2)
Miscellaneous
      Autism 8 (16)
      ADHD 3 (6)
      Growth retardation 3 (6)
      Choanal atresia 2 (4)
      Hypogammaglobulinemia 1 (2)
*; More than one abnormality may be observed in one patient, 
MCA; Multiple congenital anomalies, ID; Intellectual disability, DD; 
Developmental delay, ASD; Atrial septal defect, VSD; Ventricular septal 
defect, PS; Pulmonic stenosis, PDA; Patent ductus arteriosus, TOF; 
Tetralogy of fallot, PFO; Patent foramen ovale, AS; Aortic stenosis, SNHL; 
Sensorineural hearing loss, UDT; Undescended testis/testes, and ADHD; 
Attention deficit/hyperactivity disorder.
The clinical findings for patient 9 were compared with 
the previously reported patients in the literature and the 
ECARUCA database (http://www.ecaruca.net) (9) in 
Table 3.
The cytogenetic and molecular cytogenetic results of 8 
patients were reported in detail in Table 4.
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Table 3: The clinical features of patient 9 compared to those previously reported with 18p deletion, 18q duplication, mosaic ring(18), and full trisomy

































Growth retardation + +
ID/DD + + + + + + + + +
Microcephaly + + +
Defects of CNS + +
Speech disorder + + + +
Hypotonia + + - + + + +
Heart defects - - + +
Optic nerve hypoplasia - +
Ptosis of eyelids + + - + + -
Strabismus + + + + -
Hypertelorism + - - + + +
Down/up slanting-
palpebral fissures
+ - - - + + +
Low-set ears + + - - + + + +
Wide nasal bridge + +
Long/short philtrum - - + + +
High-arched palate - + - + + + +
Micrognathia - - + + + +
Clinodactyly + - + + + +
Rocker bottom feet + +
Short stature + + + +
IgA deficiency - + - + +
IgG deficiency - - + +
IgM deficiency - - + +
Feeding problem + +
Genital malformations - - - - + +
Hernia + - + - +
ID; Intellectual disability, DD; Developmental delay, CNS; Central nervous system, +; Indicates presence, -; Indicates absence, and blank space; Indicates 
not available/not reported data.
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Table 4: Characterization of chromosomal abnormalities detected in 8 patients with MCA
Patient Cytogenetic band Chromosomal sequence Size Del/Dup Significant genes Known syndromes Inheritance








5 5q35.2q35.3 175,559,373- 177,422,731 1.86 Mb Del 25 OMIM genes 
including
NSD1
Sotos syndrome De novo
9 18p11.21p11.32 148,992-13,448,995 13.3 Mb Del 44 OMIM genes
TGIF1, LIPIN 2, 
LAMA1
- De novo




18p11.21q21.31  (Mosaic ring, 37% of cells) - Dup - -





17 12q15-qter - - Dup HAND2 - Maternal
4q33 - - Del - -














35 16p13.3 - - Del CREBBP Rubinstein-
Taybi syndrome 1
De novo





De novo or 
Paternal
10q26.3  135243049-135372492 130 Kb Dup CYP2E1, SYCE1 -
MCA; Multiple congenital anomalies, Del; Deletion, and Dup; Duplication.
Patient 17, an 8.5-month-old boy born to non-
consanguineous parents with DD, infantile spasms and 
myoclonic jerks, abnormal EEG, PDA, ASD, Facial 
dysmorphic features, Hypotonia, and Corpus callosum 
hypoplasia (Table 1), showed an additional segment of 
12q15-qter origin on 4q33 in karyotype analysis. The 
patient father’s karyotype was normal, but his mother’s 
karyotype showed a reciprocal balanced translocation 
between long arms of chromosomes 4 and 12 
46,XX,t(4;12)(q33;q15). The clinical features of patient 
17 were compared with those of the previously reported 
patients who had overlapping genotypes with patient 17. 
The information was obtained from  the ECARUCA (9) 
and DECIPHER (16) databases (Table 5). 
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 Table 5: The clinical features of patient 17 compared to the cases previously reported with partial 12q duplications and those with partial deletions of 4q






























4q33-qter del  
(patient 17)
Sex M F M F M F M M M
Growth retardation + + - +
ID + + +Severe + - + + +
Seizures/Abnormal 
EEG
+ + - +







Hypotonia + + - +
Heart defects - + + +
Short neck + + - + +
Hypertelorism + + - +
Epicanthal folds + + + - +
Slanting palpebral 
fissures
Up Up Up Up Down
Malformed ears + + - + + + +
Low-set ears + + + - +
Micrognathia + + + + + - -
Flat malar chin/flat mid-
face
+ + +
Thin upper/lower  lip + + + -
High-arched palate + - +
Down-turned corners of 
the mouth
+ + + + -
Abnormality of the teeth + + + -
Abnormal palmar 
creases
+ + - + +




Anteverted nares + + + + + +
Depressed/flat nasal 
bridge
+ + - - +
High/prominent nasal 
bridge
+ + + - -
Wide  nasal bridge + + +
Short stature + + + + - -
Foot deformity + + + + + +
Sacral dimple/sinus + + + + - +
Imperforated anus - +
Hearing loss - +Bilateral
Umbilical hernia +
Cryptorchidism + + - +
Small kidneys +
EEG; Electroencephalography, F; Female, ID; Intellectual disability, M; Male, +; Presence, -; Absence, and blank spaces indicate not available/not reported data.
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Patient 41, a 10-year-old boy born to non-consanguineous 
healthy young parents with ID, autistic behavior, impaired 
social functioning, facial dysmorphic features, language 
delay, and microcephaly, bilateral SNHL, polydactyly 
(4 limbs), epilepsy, abnormal EEG, hypotonia, and 
trigonocephaly (Table 1), carried a terminal deletion 
of 3p in conventional cytogenetic characterization: 46, 
XY,del(3)(p25.3p26.3) (Fig.1C). The karyotype analysis 
of the proband’s mother showed an apparently normal 
female karyotype, but the father’s blood sample was 
unavailable. Further investigations using array-CGH 
confirmed 11.4 Mb terminal deletion of the short arm of 
chromosome 3 and about 130 Kb terminal duplication 
of the long arm of chromosome 10. Given the terminal 
10q duplication, the probability that the 3p26.3p25.3 
deletion was inherited from his father with 46,XX,t(3;10)
(p26.3p25.3; q26.3) is high.
The karyotype of patient 27, an 18-year-old boy from 
non-consanguineous parents and born to a 31-year-old 
G7P6L6A1 mother at term, had been reported as a normal 
male in his medical documents. The result of further 
investigation using P245 Microdeletion Syndromes-1 
kit was negative for the microdeletion/microduplication 
syndromes. The clinical features were ID, tetralogy of 
fallot (TOF), microcephaly, severe scoliosis, short stature, 
speech delay, and facial dysmorphic features (Table 1). 
In the conventional cytogenetic investigation repeated, a 
suspicion for terminal 1q deletion was observed. Array-
CGH was performed and reported two inherited CNVs: 
A 7.2 Mb deletion of the terminal end of 1q43q44 and a 
541 Kb duplication of Xp22.33. The array-CGH analyses 
performed for both of the parents were normal. 
Patient 1 was a 14-month-old girl from healthy 
and young non-consanguineous parents born through 
normal vaginal delivery to a G1P1L1A0 mother at 
term. The clinical characteristics were ID, intrauterine 
growth restriction (IUGR), hypotonia, hypothyroidism, 
supravalvular aortic stenosis, supravalvular pulmonary 
stenosis, left visual defect, attention deficit/hyperactivity 
disorder, strabismus, long philtrum, and thick lips. 
Conventional cytogenetic analysis was normal. MLPA 
screening demonstrated a deletion of 7q11.23 consistent 
with Williams-Beuren syndrome. Further assays using 
array-CGH confirmed about 1.37 Mb deletion including 
22 OMIM genes. Array-CGH analyses of the parents 
were normal.
Patient 5 was a 5.5-year-old girl, born through normal 
vaginal delivery to healthy and young non-consanguineous 
parents following a full-term pregnancy. Her mother was 
G2P1L1A1. She had suffered constipation for the first 
six months after birth. At the age of 14 months, the renal 
cortical scan revealed lesser activity in the lower pole of 
the left kidney because of pyelonephritis. During voiding 
cystourethrogram, severe urinary tract reflux was present 
in the left kidney. She also had a large ASD, ID, seizure 
attacks, autistic behavior, macrocephaly, dolicocephaly, 
frontal bossing, fish-shaped mouth, sparse hair, and joint 
laxity. She can say up to 5 words. The karyotype analysis 
was normal. MLPA assay revealed a deletion of 5q35.3 
consistent with Sotos syndrome. Further investigations 
using array-CGH confirmed 1.86 Mb deletion including 
25 OMIM genes. Array-CGH analyses of the parents 
were normal.
Patient 13 was a 3-year-old boy who was the 
product of the first pregnancy and cesarean delivery of 
nonconsanguineous parents. The clinical features were 
widow’s pick hair, down-slanting palpebral fissures, long 
eyelashes, deep set eyes, malformed, posteriorly rotated 
and low set ears, upward nose and nares, long philtrum, 
small mouth, high arched palate, high pitched cry, wheezing 
respiratory sounds, cardiac surgery scar, simian crease, 5th 
toe clinodactyly, umbilical hernia, sacral mongolian spot, 
overriding of 1st toe with 2nd toe, right lower limb paresis, 
joint contractures, right sided tippy-toed walking and 
bilateral undescended testes. Axial spiral CT-scan of the 
brain without contrast media showed bilateral pachygyria 
at frontotemporoparietal lobes due to abnormal neuronal 
migration. The karyotype analysis was normal. MLPA 
assay detected a deletion of 22q11.21 consistent with 
DiGeorge syndrome. Further investigations using array-
CGH confirmed 2.86 Mb deletion including 41 OMIM 
genes, arr 22q11.21 (18,706,023-21,561,492) x1 dn. 
Array-CGH analyses of the parents were normal.
Patient 35 was a 7-month-old girl born through cesarean 
section to a healthy consanguineous (first cousin) couple. 
Her mother was G1P1L1A0. She had bilateral cataracts, 
hypertelorism, left ptosis, frontal bossing, low set ears, long 
philtrum, broad nasal bridge, micrognathia, a borderline lactic 
acid and normal creatinine in urine, ascending aorta dilatation, 
peripheral pulmonary stenosis, and small ASD. Conventional 
cytogenetic analysis showed a normal female karyotype. The 
MLPA technique indicated a deletion of 16p13.3 consistent 
with Rubinstein-Taybi syndrome. The sample assay was 
carried out twice. The parents’ karyotype analyses and MLPA 
assays were normal.
Discussion
Based on several studies, the diagnostic yields of 
conventional cytogenetic studies in patients with MCA, 
global DD, and autism spectrum disorders, barring the 
known trisomy syndromes, have been reported to be 
about 3% (20). In this study, we identified chromosomal 
abnormalities, microdeletions, and  microduplications 
for 8 patients (16%) using conventional karyotyping 
technique [3 patients (6%)], MLPA method [4 patients 
(8%)], and array-CGH [1 patient (2%)]. In addition to the 
sample size limitations, the adoption of inflexible criteria 
for selecting patients and the design type of the study 
could have contributed to the raising the diagnostic rate 
of this study.
Well-defined microdeletion syndromes were the most 
common cause of MCA in this study, consistent with 
the results of previously reported studies (21). The 
clinical features of four patients 1, 5, 13, and 35 are 
congruent with known microdeletion syndromes namely 
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Williams-Beuren syndrome, Sotos syndrome, DiGeorge 
syndrome, and Rubinstein-Taybi syndrome, respectively. 
Consequently, they are not discussed in detail.
According to a hypothesis, two critical regions are 
within the long arm of chromosome 18 (18q), including 
18q12.1-q21.2 and 18q22.3-qter. Duplication occurrence 
is essential in both proximal and distal regions in order 
to cause the typical clinical features of a trisomy 18 to 
be manifested (12). In patient 9, the former duplication 
is considered as a mosaic trisomy and the latter as a full 
trisomy. 
As a chromosomal abnormality, partial deletion of 18p 
is more common than partial duplication of 18q (22). 
Mostly, a balanced translocation or inversion carried by 
one parent is the leading cause of partial trisomy of 18q 
(15). The real mechanism of mosaic ring 18 formation in 
patient 9 is unknown. Although his parents’ karyotypes 
were normal, there was a recombinant pattern of pericentric 
inversion and an extra ring in the patient’s karyotype. The 
possible mechanism for the formation of both derivative 
and ring chromosome 18 could, most probably, have 
initiated with an inverted chromosome 18 (p11.21– 
q21.31), created during meiosis in the gamete of one 
parent (23). Postzygotic mitosis resulted in two partially 
q duplicated and partially p deleted recombinants (22). 
The genetic size of 18p is almost 16 Mb with a common 
breakpoint cluster located in the pericentromeric region 
with a length of 4 Mb. The partial deletion of 18p in this 
patient was inside the breakpoint cluster spanning 13.3 
Mb. It should be noted that the 18q21.3 segment is one 
of the common fragile sites of chromosome 18 (24). One 
of the recombinants had seemed to have two breakpoints 
in 18q21.31 and 18p11.21 bands and the sticky ends of 
the segment between them fused and formed the ring 
chromosome 18. The broken segments were lost and some 
of the rings created were deleted in the next mitoses. The 
formation of ring chromosome 18 may be a novel escape 
mechanism in this patient with a pentasomy of 18q21.31-
qter segment (25).
Most clinical phenotypes of patient 9 overlapped 
with the clinical manifestations of partial 18p deletion, 
partial 18q duplication, and mosaic ring chromosome 18 
syndromes. The phenotypic variations could be explained 
based on the locations and the lengths of the duplicated 
or deleted segments with a mosaic triplicated segment 
between them considering the co-occurrence of different 
types of chromosome 18 abnormalities in this patient.
Litzman et al. (13) reported an agammaglobulinemic 
14-year-old girl with a mosaic ring chromosome 18. 
Her karyotype turned out to be: 45, XX,-18[5]/46, XX, 
dic r(18)[6]/46, XX, r(18)[89]. IgA deficiency/absence 
with normal ranges of IgG and IgM has been previously 
reported in association with 18p deletion (11). To the 
best of our knowledge, the proband is the first patient to 
be reported with partial monosomy of 18p, partial 18q 
duplication, and an extra mosaic ring chromosome 18 
associated with hypogammaglobulinemia.
Based on the information obtained, no patient has 
been previously reported with partial duplication of 12q 
with the breakpoint at 12q15 to qter. However, although 
chromosome 4q deletions occur rarely, 4q33-qter 
deletions have been reported several times (17). It seems 
that some clinical features of patient 17 like hypoplasia of 
corpus callosum, hypotonia, and high-arched palate are 
also observed in the cases with partial 12q duplication. In 
contrast, some of the other physical characteristics such as 
heart defects, flat midface, camptodactyly, and depressed 
nasal bridge are consistent with phenotypic features of 
terminal deletion of 4q33-qter. However, a number of 
major anomalies in patient 17 including bilateral hearing 
loss, imperforated anus, umbilical hernia, and small 
kidneys have not been reported in the patients with partial 
12q duplication or partial 4q deletion. The large size of 
12q15-qter duplication could be the cause of these extra 
phenotypes. Homo sapiens HAND2 gene located on 
4q34.1 has been known as the responsible gene whose 
proteins play a crucial role in developing ventricular 
chambers, cardiac morphogenesis, forming right ventricle 
and aortic arch arteries as well as developing limb and 
branchial arch. The haploinsufficiency of this gene in 
4q deletion may justify inborn heart anomalies (i.e., 
VSD and ASD), growth retardation, ID, digital anomaly 
(i.e., clinodactyly and oligodactyly), and craniofacial 
dysmorphism including a cleft palate (26).
Approximately 11.4 Mb deletion of the distal segment 
of 3p containing 46 OMIM genes has led to severe and 
different phenotypes in patient 41.
The distal deletion of 3p is a rare contiguous gene 
syndrome with the variable spectrum of major anomalies 
such as developmental delay, growth retardation, 
autism, hearing loss, renal anomalies, heart defects, and 
craniofacial dysmorphic presentations. Given common 
facial dysmorphic features and ID among patients with 
intragenic sequence variants and microdeletions affecting 
SETD5, it has been suggested that this gene plays a vital 
role in ID and also has a significant contribution to the 
core phenotype of 3p deletion syndrome (27). 
It seems that ID severity in patient 41 is due to the 
haploinsufficiency association of SETD5 and BRPF1 
genes. CHL1 gene deletion associated with mild ID 
and learning difficulties (28) may also contribute to this 
severity. Furthermore,  some clinical manifestations 
specially ptosis and short stature may occur because of 
BRPF1 gene deletion (29).
The autistic behavior of patient 41 may be because 
of CNTN4 (contactin 4), previously introduced as a 
strong candidate gene associated with autism spectrum 
disorders (30). Two genes namely SLC6A1 and SLC6A11 
encoding GABA transporter proteins have been proposed 
as possible candidates for seizures/EEG abnormalities, 
ataxia, and ID (31).
1q43q44 deletion in patient 27 with the size of 7.2 
Mb included 126 HGNC and 19 OMIM genes. Of these 
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genes, AKT3 gene haploinsufficiency has been linked 
with microcephaly in previously reported cases with 
1q43q44 deletion syndrome (32). However, because of 
the presentation of microcephaly in the patients with intact 
AKT3 gene, the other candidate genes such as NLRP3, 
HNRNPU, SMYD3, and KIF26B have been suggested 
to cause microcephaly (33). Nonetheless, AKT3 deletion 
may explain the severity of microcephaly in patient 27.
Corpus callosum agenesis/hypoplasia and epilepsy are 
mostly associated with deletions of ZBTB18 and HNRNPU 
genes in the patients with 1q43q44 deletion syndrome, 
respectively (34). However, none of these symptoms is 
demonstrated in the present case despite ZBTB18 and 
HNRNPU disruptions. Recent studies have suggested 
that modifier genes or two-hit hypothesis may explain 
variable expressions among some patients with identical 
microdeletions. Another CNV is a disruptive single-
base-pair mutation in a related gene or an environmental 
event which influences the phenotype. These are all the 
examples of the second hit (35).
Patient 27 also had a duplication of about 541 Kb in 
Xp22.33 containing PLCXD1, GTPBP6 and PPP2R3B 
genes as well as exons 1-3 and part of exon 4 of SHOX gene. 
PPP2R3B is one of the four major Ser/Thr phosphatases 
and negatively affects cell growth and division. PPP2R3B 
performs a regulatory control over the starting of DNA 
replication and its overexpression results in G1 phase cell 
cycle arrest (36).  
There has been a variable impact on stature due to 
duplications of the region PAR1 containing the SHOX 
gene. Although some studies point to a correlation 
between SHOX gene deletions and short stature and Leri-
Weill dyschondrosteosis, others have found some patients 
with the same clinical features who had partial or full 
duplications of SHOX gene. Bunyan et al. (37) reported 
a duplication of the exons 1-3 of the SHOX gene in a 
patient who had only short stature with no other clinical 
findings inherited from the proband’s affected mother. 
Co-overexpression of PPP2R3B and SHOX genes seems 
to have a synergistic effect on our proband’s short stature 
severity.  
Conclusion   
In this study, 50 patients with MCA were studied in 
terms of chromosomal abnormalities and microdeletion/
microduplication syndromes. A patient was introduced with 
46,XY, der(18)[12]/46,XY, der(18), +mar[8] dn as a novel 
case of MCA associated with hypogammaglobulinemia. 
Afterwards, given the highly complex and rare nature 
of the patient’s chromosomal abnormality, a novel 
mechanism was proposed to explicate the formation of 
both derivative and ring chromosome 18. Furthermore, 
a new 12q abnormality was found which had not been 
reported previously. In addition, a novel association of an 
Xp22.33 duplication with 1q43q44 deletion syndrome was 
demonstrated. The phenotypic analysis of the introduced 
patients can be useful for further phenotype-genotype 
correlation studies.
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